SCH-01-2014

SCH-01-2014 - Midazolam versus propofol sedation during ERCP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025385

Enrollment

100

Registered

2016-12-23

Start date

2014-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Finished

Interventions

Midazolam based sedation Sedation safety and efficacy measurement according to the two protocol. Propofol based sedation Sedation safety and efficacy measurement according to the two protocol.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pancreatobiliary disease needing therapeutic ERCP

Exclusion criteria

Exclusion criteria: Older than 80 years

Design outcomes

Primary

Measure	Time frame
Cardiopulmonary complications: hypoxia, hypotension, tachycardia, and bradycardia	—

Countries

Asia(except Japan)

Contacts

Public ContactTaehoon Lee

Soonchunhyang University Cheonan Hospital Gastroenterology

thlee9@schmc.ac.kr+82-41-570-3662

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026